Saturday, November 22, 2025 3:31:10 PM
Happy holiday as well, to you and your family, Steve.
Of course we know looking at the very short time frame charts should be for entries and exits. I was making a general comment about watching price action . I think we are sensing the same thing about this current picture. And what could develop in these next critical weeks, with the next news and how price reacts, and we don’t know what that news will be, positive or negative, mildly negative or positive, and then how strongly would the short attack spin managers try to attack the news, like we always see them do to AVXL. We could see positive news happen and the shorting gamers twist it negatively with a hit piece, which stifles a rally and might even send the price down. And this manipulation can happen for the entire 3 or 4 month period.
This time in the life cycle and development of the investment seems like it might be the most critical time in these last 14 years. And how it looks now, after such a major sell down, to 3 dollars, from 7/6.50 … it didn’t even pause at the 5 dollar support zone. This acted like a slam to the Extreme Bottom. There’s a lot we can brainstorm about analyzing this. Probably better to discuss in my TA forum .
I don’t mind buying shares here at 3 dollars, but we have to be careful in case the selling powers are still able and intend to push it down to 2.00-2.40. In the next few weeks. Then the December news comes, this whole time period will be tricky to navigate. My basic target zones to buy are (small lots, carefully planned,constant monitoring of the price action, as it aims towards 3.00, then 2.50 area, 2.40/2.30 area, 2.25. But it’s also about the way the price action moves, how it gyrates, up and down, how it behaves at resistance and how it rolls over and tumbles down to support. It’s a learned skill to understand what you’re seeing when watching the 1 minute and 5 minute price action. Do you know about the famous trader, Jesse Livermore? He developed his skills as a price board number changer on the exchange trading floor in the early 1900’s. Interesting book.
Of course we know looking at the very short time frame charts should be for entries and exits. I was making a general comment about watching price action . I think we are sensing the same thing about this current picture. And what could develop in these next critical weeks, with the next news and how price reacts, and we don’t know what that news will be, positive or negative, mildly negative or positive, and then how strongly would the short attack spin managers try to attack the news, like we always see them do to AVXL. We could see positive news happen and the shorting gamers twist it negatively with a hit piece, which stifles a rally and might even send the price down. And this manipulation can happen for the entire 3 or 4 month period.
This time in the life cycle and development of the investment seems like it might be the most critical time in these last 14 years. And how it looks now, after such a major sell down, to 3 dollars, from 7/6.50 … it didn’t even pause at the 5 dollar support zone. This acted like a slam to the Extreme Bottom. There’s a lot we can brainstorm about analyzing this. Probably better to discuss in my TA forum .
I don’t mind buying shares here at 3 dollars, but we have to be careful in case the selling powers are still able and intend to push it down to 2.00-2.40. In the next few weeks. Then the December news comes, this whole time period will be tricky to navigate. My basic target zones to buy are (small lots, carefully planned,constant monitoring of the price action, as it aims towards 3.00, then 2.50 area, 2.40/2.30 area, 2.25. But it’s also about the way the price action moves, how it gyrates, up and down, how it behaves at resistance and how it rolls over and tumbles down to support. It’s a learned skill to understand what you’re seeing when watching the 1 minute and 5 minute price action. Do you know about the famous trader, Jesse Livermore? He developed his skills as a price board number changer on the exchange trading floor in the early 1900’s. Interesting book.
Recent AVXL News
- Anavex Life Sciences Highlights New Scientific Findings on Shared Biology Between Autism and Alzheimer’s Disease • GlobeNewswire Inc. • 04/14/2026 11:30:00 AM
- Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/07/2026 11:30:00 AM
- Anavex withdraws EU approval filing for Alzheimer’s therapy • IH Market News • 03/30/2026 12:39:26 PM
- Anavex Life Sciences Provides Comprehensive Regulatory Update • GlobeNewswire Inc. • 03/30/2026 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2026 08:06:00 PM
- Anavex withdraws EU marketing application for Alzheimer’s therapy blarcamesine • IH Market News • 03/25/2026 02:06:58 PM
- Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/25/2026 11:30:00 AM
- Anavex Life Sciences Presents New Data from its AD-004 Phase IIb/III Trial at AD/PD 2026 Conference Demonstrating Consistent Correlation Between the Treatment Effect of Oral Blarcamesine and Preservation of Brain Volume in Early Alzheimer’s Disease • GlobeNewswire Inc. • 03/23/2026 11:30:00 AM
- New Scientific Findings Highlight Hypothesis of Autophagy Failure as a Precursor of Amyloid Beta and Tau Pathology in Alzheimer’s Disease • GlobeNewswire Inc. • 03/20/2026 11:30:00 AM
- Anavex Life Sciences Presents Significant Treatment Effects of Blarcamesine in New Advanced Alpha-Synuclein Model of Parkinson’s Disease at AD/PD 2026 Conference • GlobeNewswire Inc. • 03/17/2026 11:30:00 AM
- Anavex Life Sciences to Present at the Citizens Life Sciences Conference • GlobeNewswire Inc. • 03/03/2026 12:30:00 PM
- Anavex Life Sciences to Present at the 46th TD Cowen Annual Health Care Conference • GlobeNewswire Inc. • 02/25/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 11:07:01 AM
- Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of Directors • GlobeNewswire Inc. • 02/23/2026 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/09/2026 09:40:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2026 12:31:17 PM
- Anavex Life Sciences Reports Fiscal 2026 First Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/09/2026 12:30:00 PM
- Anavex Life Sciences to Announce Fiscal 2026 First Quarter Financial Results on Monday, February 9, 2026 • GlobeNewswire Inc. • 02/03/2026 12:30:00 PM
- Anavex Joins ACCESS-AD, a Major Initiative Funded by the European Commission, Through the Clinical Evaluation of Blarcamesine as Part of a Precision Medicine Approach in Alzheimer’s Disease • GlobeNewswire Inc. • 01/13/2026 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2026 10:26:26 PM
- Edelson Lechtzin LLP Announces an Investigation of Anavex Life Sciences Corp. (NASDAQ: AVXL) and Encourages Investors with Substantial Losses Contact the Firm • PR Newswire (US) • 01/09/2026 01:13:00 AM
- Anavex Life Sciences Appoints Senior Vice President Global Head of Neurology • GlobeNewswire Inc. • 01/08/2026 12:30:00 PM
- Anavex Life Sciences Receives FDA Feedback on Alzheimer’s Disease Program • GlobeNewswire Inc. • 01/06/2026 12:30:00 PM
- Anavex Life Sciences Submitted Request for EMA to Re-Examine Its Opinion • GlobeNewswire Inc. • 12/18/2025 12:30:00 PM
- Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease • GlobeNewswire Inc. • 12/12/2025 09:05:00 PM
